Literature DB >> 18291460

Spinal cord lipoma without dysraphism in the infancy that extends intracranially. Case report and review of the literature.

Manuel Vila Mengual1, Pablo Miranda Lloret, Antonio López González, Juan A Simal, Jose A Alvarez Garijo.   

Abstract

BACKGROUND: Spinal intramedullary lipoma extending to the posterior fossa is very rare in children. We made a revision of the literature and report the diverse opinions and surgical procedures. CASE DESCRIPTION: We report the case of a 16-month-old male infant who was operated on in the Pediatric Neurosurgical Unit of our hospital; his clinical and surgical outcome are related.
CONCLUSION: Intramedullary lipoma of the spinal cord with intracranial extension in infancy is a very rare pathology reported in the literature. Our patient was treated with decompression and subtotal removal; he had a critical postoperative course but was recovering slowly after that. Most authors prefer incomplete resection because these lesions do not have a clear-cut margin. Another neurosurgeon performed a decompression only, without resection. Some authors performed the surgical treatment before symptom progression. Another surgeon reported that the surgical indication is debatable when the neurologic manifestations are poor or absent. The surgical indication and the strategy for treatment are controversial and they depend on the clinical situations of the patients.

Entities:  

Mesh:

Year:  2008        PMID: 18291460     DOI: 10.1016/j.surneu.2007.10.036

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  A Rare Case of Intramedullary Lipoma of Brainstem to Thoracic Cord--What to Do?

Authors:  Ishu Bishnoi; Pardaman Singh; Geetika Duggal; Sunil Sorout
Journal:  J Pediatr Neurosci       Date:  2020-06-27

2.  Intradural lipoma of the cervicothoracic spinal cord with intracranial extension.

Authors:  Ahmet Metin Sanli; Erhan Türkoğlu; Ramazan Kahveci; Zeki Sekerci
Journal:  Childs Nerv Syst       Date:  2010-01-23       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.